Top compounds associated with response to DEFB134


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.071 0.03
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.076 0.04
mRNA pluripotin CTRPv2 pan-cancer AAC -0.077 0.04
mRNA Crizotinib CTRPv2 pan-cancer AAC -0.07 0.04
mRNA foretinib CTRPv2 pan-cancer AAC -0.075 0.04
mRNA AZD7762 GDSC1000 pan-cancer AAC -0.068 0.04
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.074 0.04
mRNA ZG-10 GDSC1000 pan-cancer AAC -0.093 0.05
mRNA PIK-93 CTRPv2 pan-cancer AAC -0.073 0.05
mRNA FH535 GDSC1000 pan-cancer AAC 0.068 0.05
Download CSV